天域生物：努力通过多项举措以提升经营质量及治理水平

Core Viewpoint - Tianyu Biology (603717) emphasizes a commitment to steady operations and aims to enhance operational quality and governance through various initiatives [1] Group 1: Business Strategy - The company focuses on the development of its core business, implementing cost reduction and efficiency improvement measures, and enhancing operational quality and core competitiveness [1] - There is an accelerated effort to collect accounts receivable [1] Group 2: Capital Operations - The company has disclosed a plan for a specific issuance of A-shares for 2025, indicating ongoing capital operations to strengthen its capital base and risk resilience [1] Group 3: Risk Management - Current guarantees mainly support the business development and operations of its controlling subsidiaries, which are stable, and the overall guarantee risk is manageable [1] - There are no indications of harm to the company or minority shareholders' interests [1]